Scientific Reports (Jun 2022)

Effect of diabetes on patient-reported outcome measures at one year after laminoplasty for cervical spondylotic myelopathy

  • Kosei Nagata,
  • Junya Miyahara,
  • Hideki Nakamoto,
  • Naohiro Kawamura,
  • Yujiro Takeshita,
  • Akiro Higashikawa,
  • Takashi Ono,
  • Masayoshi Fukushima,
  • Rentaro Okazaki,
  • Nobuhiro Hara,
  • So Kato,
  • Toru Doi,
  • Yuki Taniguchi,
  • Yoshitaka Matsubayashi,
  • Sakae Tanaka,
  • Yasushi Oshima

DOI
https://doi.org/10.1038/s41598-022-13838-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Although patients with diabetes reportedly have more peripheral neuropathy, the impacts of diabetes on postoperative recovery in pain and patient-reported outcome measures (PROMs) after laminoplasty for cervical spondylotic myelopathy (CSM) is not well characterized. The authors aimed to elucidate the effects of diabetes on neck/arm/hand/leg/foot pain and PROMs after laminoplasty CSM. The authors retrospectively reviewed 339 patients (82 with diabetes and 257 without) who underwent laminoplasty between C3 and C7 in 11 hospitals during April 2017 –October 2019. Preoperative Numerical Rating Scale (NRS) scores in all five areas, the Short Form-12 Mental Component Summary, Euro quality of life 5-dimension, Neck Disability Index, and the Core Outcome Measures Index-Neck) were comparable between the groups. The between-group differences were also not significant in NRS scores and PROMs one year after surgery. The change score of NRS hand pain was larger in the diabetic group than the nondiabetic group. The diabetic group showed worse preoperative score but greater improvement in the Short Form-12 Physical Component Summary than the nondiabetic group, following comparable score one year after surgery. These data indicated that the preoperative presence of diabetes, at least, did not adversely affect pain or PROMs one year after laminoplasty for CSM.